The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD

NCT ID: NCT04368689

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-18

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project is being done to explore the effects floating has on individuals who have a history of trauma with stress related symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This pilot study looks to further the current floatation-based REST literature by exploring the therapy's effectiveness within a community-based sample of adults with PTSD. This type of sample allows the study the opportunity to recruit both veteran and civilian subjects, two populations that can suffer from this clinical diagnosis and stand to benefit from this therapy. This study will:

1. Evaluate the psychological effects of floating for a clinical, community sample with PTSD.
2. Evaluate the physiological effects of floating for a clinical, community sample with PTSD.
3. Evaluate the subjective effects of floating for a clinical, community sample with PTSD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Traumatic Stress Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Floating

Participants have 3 Floatation sessions that last up to 90 minutes. Each spaced about a week apart.

Group Type EXPERIMENTAL

Floatation-based reduced environmental stimulation therapy

Intervention Type OTHER

Completion of 3 float session that can last for up to 90 minutes each session, each spaced approximately one week apart

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Floatation-based reduced environmental stimulation therapy

Completion of 3 float session that can last for up to 90 minutes each session, each spaced approximately one week apart

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has posttraumatic stress disorder (PTSD) as confirmed by the PCL-5
* 18-60 years of age

Exclusion Criteria

* History of neurological conditions (e.g., epilepsy, stroke, severe traumatic brain injury, Parkinson's disease, Alzheimer's disease or other forms of dementia)
* Any skin conditions or open wounds that could cause pain when exposed to saltwater
* Has floated previously
* Has Schizophrenia spectrum or other psychotic disorders
* Refuses to adhere to the Pre-Float Checklist
* Non-English speaking
* Inability to lay comfortably in a shallow pool of water
* Refuses participation in the floatation-REST sessions
* Refuses to sign the Float Liability Waiver prior to floating
* No Communicable disease (e.g.- HIV, Hepatitis A, B\& C, tuberculosis, or measles)
* No psychoactive drugs or laxatives within the past week from scheduled float. Psychoactive drugs include, but are not limited to: methylenedioxymethamphetamine (MDMA), lysergic acid diethylamide (LSD), psilocybin, peyote, phencyclidine, ketamine).No recreational drug use (e.g.tetrahydrocannabinol,abuse of prescription medicine) day before or day of study visit. No antihistamine that causes drowsiness and no alcohol the day of the float sessions.
* Lack of control of bodily functions prior to scheduled float
* Fresh tattoos that would inhibit ability to float (consult with tattoo artist)
* Colored/dyed hair less than one week old from scheduled float
* Body tanning/spay/paint less than one week old from scheduled float
* Active suicidal ideation
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical College of Wisconsin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Terri deRoon Cassini

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Terri deRoon-Cassini, PhD

Role: PRINCIPAL_INVESTIGATOR

Medical College of Wisconsin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Feinstein JS, Khalsa SS, Yeh HW, Wohlrab C, Simmons WK, Stein MB, Paulus MP. Examining the short-term anxiolytic and antidepressant effect of Floatation-REST. PLoS One. 2018 Feb 2;13(2):e0190292. doi: 10.1371/journal.pone.0190292. eCollection 2018.

Reference Type BACKGROUND
PMID: 29394251 (View on PubMed)

Feinstein JS, Khalsa SS, Yeh H, Al Zoubi O, Arevian AC, Wohlrab C, Pantino MK, Cartmell LJ, Simmons WK, Stein MB, Paulus MP. The Elicitation of Relaxation and Interoceptive Awareness Using Floatation Therapy in Individuals With High Anxiety Sensitivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jun;3(6):555-562. doi: 10.1016/j.bpsc.2018.02.005. Epub 2018 Mar 9.

Reference Type BACKGROUND
PMID: 29656950 (View on PubMed)

Fine TH, Turner JW Jr. The effect of brief restricted environmental stimulation therapy in the treatment of essential hypertension. Behav Res Ther. 1982;20(6):567-70. doi: 10.1016/0005-7967(82)90035-3. No abstract available.

Reference Type BACKGROUND
PMID: 7159352 (View on PubMed)

Forgays, D. G., & Belinson, M. J. (1986). Is flotation isolation a relaxing environment?. Journal of Environmental Psychology, 6(1), 19-34.

Reference Type BACKGROUND

Jacobs GD, Heilbronner RL, Stanley JM. The effects of short term flotation REST on relaxation: a controlled study. Health Psychol. 1984;3(2):99-112. doi: 10.1037//0278-6133.3.2.99.

Reference Type BACKGROUND
PMID: 6399246 (View on PubMed)

Kjellgren A, Sundequist U, Norlander T, Archer T. Effects of flotation-REST on muscle tension pain. Pain Res Manag. 2001 Winter;6(4):181-9. doi: 10.1155/2001/768501.

Reference Type BACKGROUND
PMID: 11854763 (View on PubMed)

Koula, G. M., Kemp, J. C., Keane, K. M., & Belden, A. D. (1990). Replication of a clinical outcome study on a hospital-based stress management and behavioral medicine program utilizing flotation REST and biofeedback. In Restricted Environmental Stimulation (pp. 202-209). Springer, New York.

Reference Type BACKGROUND

Lilly, J.C. & Shurley, J.T. (1961).

Reference Type BACKGROUND

O'Leary, D. S., & Heilbronner, R. L. (1990). Flotation REST and information processing: A reaction time study. In Restricted Environmental Stimulation (pp. 113-124). Springer New York.

Reference Type BACKGROUND

Pudvah, M. B., & Rzewnicki, R. (1990). Six months in the tank: Long-term effects of flotation isolation on state anxiety, hostility, and depression. Restricted Environmental Stimulation: Theoretical and empirical developments in flotation REST, 169-173.

Reference Type BACKGROUND

Schulz P, Kaspar CH. Neuroendocrine and psychological effects of restricted environmental stimulation technique in a flotation tank. Biol Psychol. 1994 Mar;37(2):161-75. doi: 10.1016/0301-0511(94)90029-9.

Reference Type BACKGROUND
PMID: 8003591 (View on PubMed)

Shurley, J. T. (1960). Profound experimental sensory isolation. American Journal of Psychiatry, 117(6), 539-545.

Reference Type BACKGROUND

Turner Jr, J., Gerard, W., Hyland, J., Nieland, P., & Fine, T. (1993). Effects of wet and dry flotation REST on blood pressure and plasma cortisol. In Clinical and Experimental Restricted Environmental Stimulation (pp. 239-247). Springer New York.

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRO00032660

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Targeted Plasticity Therapy for PTSD
NCT06266364 RECRUITING NA
Non Invasive Brain Stimulation for PTSD
NCT02442843 COMPLETED EARLY_PHASE1
Effects of Mindfulness on PTSD
NCT03484390 COMPLETED NA
PTSD Treatment for Incarcerated Men and Women: WPP
NCT05432817 ACTIVE_NOT_RECRUITING NA
Acupuncture for PTSD
NCT02869646 COMPLETED NA